Pacific Edge Limited PEB.AX Stock
Pacific Edge Limited Price Chart
Pacific Edge Limited PEB.AX Financial and Trading Overview
| Pacific Edge Limited stock price | 0.08 AUD |
| Previous Close | 0.09 AUD |
| Open | 0.09 AUD |
| Bid | 0.09 AUD x N/A |
| Ask | 0.09 AUD x N/A |
| Day's Range | 0.08 - 0.09 AUD |
| 52 Week Range | 0.08 - 0.73 AUD |
| Volume | 46.5K AUD |
| Avg. Volume | 77.79K AUD |
| Market Cap | 68.07M AUD |
| Beta (5Y Monthly) | 0.873946 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PEB.AX Valuation Measures
| Enterprise Value | -2015420 AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.2363741 |
| Price/Book (mrq) | 0.8235294 |
| Enterprise Value/Revenue | -0.096 |
| Enterprise Value/EBITDA | 0.064 |
Trading Information
Pacific Edge Limited Stock Price History
| Beta (5Y Monthly) | 0.873946 |
| 52-Week Change | -84.91% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.73 AUD |
| 52 Week Low | 0.08 AUD |
| 50-Day Moving Average | 0.36 AUD |
| 200-Day Moving Average | 0.41 AUD |
PEB.AX Share Statistics
| Avg. Volume (3 month) | 77.79K AUD |
| Avg. Daily Volume (10-Days) | 458.78K AUD |
| Shares Outstanding | 810.36M |
| Float | 743.93M |
| Short Ratio | N/A |
| % Held by Insiders | 8.71% |
| % Held by Institutions | 30.11% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -128.20% |
| Operating Margin (ttm) | -152.40% |
| Gross Margin | 55.55% |
| EBITDA Margin | -149.57% |
Management Effectiveness
| Return on Assets (ttm) | -19.43% |
| Return on Equity (ttm) | -28.21% |
Income Statement
| Revenue (ttm) | 21.03M AUD |
| Revenue Per Share (ttm) | 0.03 AUD |
| Quarterly Revenue Growth (yoy) | 65.00% |
| Gross Profit (ttm) | 11.68M AUD |
| EBITDA | -31461000 AUD |
| Net Income Avi to Common (ttm) | -26965000 AUD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 77.79M AUD |
| Total Cash Per Share (mrq) | 0.1 AUD |
| Total Debt (mrq) | 1.22M AUD |
| Total Debt/Equity (mrq) | 1.48 AUD |
| Current Ratio (mrq) | 11.109 |
| Book Value Per Share (mrq) | 0.102 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25575000 AUD |
| Levered Free Cash Flow (ttm) | -19389000 AUD |
Profile of Pacific Edge Limited
| Country | Australia |
| State | N/A |
| City | Dunedin |
| Address | Centre for Innovation |
| ZIP | 9016 |
| Phone | 64 3 479 5800 |
| Website | https://www.pacificedgedx.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 114 |
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. The company operates in two segments, Commercial and Research. It offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. The company is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, it is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Q&A For Pacific Edge Limited Stock
What is a current PEB.AX stock price?
Pacific Edge Limited PEB.AX stock price today per share is 0.08 AUD.
How to purchase Pacific Edge Limited stock?
You can buy PEB.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pacific Edge Limited?
The stock symbol or ticker of Pacific Edge Limited is PEB.AX.
Which industry does the Pacific Edge Limited company belong to?
The Pacific Edge Limited industry is Diagnostics & Research.
How many shares does Pacific Edge Limited have in circulation?
The max supply of Pacific Edge Limited shares is 820.19M.
What is Pacific Edge Limited Price to Earnings Ratio (PE Ratio)?
Pacific Edge Limited PE Ratio is now.
What was Pacific Edge Limited earnings per share over the trailing 12 months (TTM)?
Pacific Edge Limited EPS is -0.03 AUD over the trailing 12 months.
Which sector does the Pacific Edge Limited company belong to?
The Pacific Edge Limited sector is Healthcare.